25 May 2023

GSK Stockmann advises FONDSGRUND on the acquisition of the “Netzwerk” property in Regensburg for an HIH Invest fund

A GSK Stockmann team led by Michael Jani provided comprehensive advice on real estate, tax and investment law to the Hamburg-based investment and asset manager FONDSGRUND Investment in connection with the acquisition of the “Netzwerk” office property in Regensburg for HIH Invest Real Estate and a club of German institutional investors.

Built in 2011, the complex comprises around 28,500 sqm of office space and 600 parking spaces. The property is DGNB Platinum certified and leased on a long-term basis to the supra-regional grid operator Bayernwerk Netz GmbH, a wholly owned subsidiary of E.ON, for use as its headquarters. The seller is the Munich-based Real I.S.

GSK Stockmann has been advising FONDSGRUND since it was established in January 2022. For 2023, FONDSGRUND is planning an anti-cyclical transaction volume of 400 million euros.

A GSK Stockmann team of lawyers across multiple sectors and locations led by Hamburg-based partner Michael Jani supported the off-market deal both in the preparation of the club deal as well as in the drafting, negotiation and execution of all transaction-related documents.

Advisers of FONDSGRUND:

GSK Stockmann: Michael Jani (real estate, lead), Petra Eckl, Dominik Berka (both tax), Felix Schill (tax and insurance), Max Wilmanns (corporate), Robert Kramer (supervisory law); associates: Robin Koza (real estate), Nicolas Hoffmann (projects & public sector), Marc Nostitz (tax).

Print


Press contact
presse@gsk.de
+49 30 203907-7763

Back

GSK Updates
  • 02 June 2023

    GSK Update: Comprehensive VAT exemption for management of alternative investment funds (AIFs) planned in Germany

    Read more
  • 17 May 2023

    GSK Update: German Tax Aspects for Inbound Investments

    Read more
  • 05 May 2023

    GSK Update: Real Estate Investments in Germany from a Tax Perspective

    Read more
Contact person

Dr. Michael Jani

Partner*

+49 40 369703-0

michael.jani@gsk.de

For reasons of better readability, we use the gender-neutral generic masculine. However, the information expressly refers to all genders.

CO2 Neutral